Tradipitant – Talk Bio

Vanda Pharmaceuticals Secures FDA Approval for NEREUS (Tradipitant), First New Motion Sickness Drug in Over 40 Years

3 weeks ago talkbio0Tagged Approved, Motion Sickness, NEREUS, Tradipitant, United States Food and Drug Administration, Vanda Pharmaceuticals, vomiting prevention

Vanda Pharmaceuticals; FDA approval; NEREUS; tradipitant; motion sickness; vomiting prevention

Vanda Ends Lawsuits Against FDA in Broad Settlement, Paving Way for Drug Review Progress

4 months ago talkbio0Tagged Clinical Trials, collaborative framework, Drug Approval, Employment Termination, Hetlioz, jet lag disorder, lawsuit, Motion Sickness, sNDA, Tradipitant, United States Food and Drug Administration, Vanda Pharmaceuticals

Vanda Pharmaceuticals; FDA; Hetlioz; jet lag disorder; tradipitant; lawsuit dismissal; collaborative framework; clinical trial hold; drug approval; sNDA; motion sickness

Vanda Pharmaceuticals Rejects Cycle’s Second Takeover Bid Amid FDA Rejection of Tradipitant

1 year ago talkbio0Tagged Acquisition, Biopharma, Gastroparesis, Rejection, Tradipitant, Twice a day, United States Food and Drug Administration, Vanda Pharmaceuticals

Vanda Pharmaceuticals, Cycle Pharmaceuticals, takeover bid, FDA rejection, tradipitant, gastroparesis, biopharma, acquisition offer

Vanda Pharmaceuticals Receives FDA Rejection for Gastroparesis Treatment, Criticizes Agency’s Decision

1 year ago talkbio0Tagged conclusory, Gastroparesis, refusal, Rejection (Psychology), Tradipitant, United States Food and Drug Administration, Vanda Pharmaceuticals

Vanda Pharmaceuticals, FDA rejection, gastroparesis treatment, tradipitant, conclusory refusal